|
Jun 11
|
Novo Nordisk, Deep Apple Launch Drug Discovery Alliance For Weight Loss Oral Therapies
|
|
Jun 11
|
NVO Stock Gains After Parvus Asset Management Builds Stake
|
|
Jun 11
|
Can Mounjaro, Zepbound Help Lilly Maintain Dominance in Obesity Space?
|
|
Jun 11
|
Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to
|
|
Jun 11
|
Nvidia Teams With Novo Nordisk to Supercharge Early-Stage Drug R&D
|
|
Jun 11
|
Novo signs $812 million weight-loss drug license deal with US biotech Deep Apple
|
|
Jun 11
|
The cheap fat jabs sending big pharma into a frenzy
|
|
Jun 10
|
Stocks to Watch Recap: Tesla, TSMC, Novo Nordisk
|
|
Jun 10
|
Eli Lilly telehealth deals to prevent sale of compounded GLP-1s
|
|
Jun 10
|
Hims & Hers stock falls after Lilly rules out partnership
|
|
Jun 10
|
Sector Update: Health Care Stocks Higher Tuesday Afternoon
|
|
Jun 10
|
Why Novo Nordisk Stock Just Popped
|
|
Jun 10
|
Novo Nordisk Launches Long-Term Study of CagriSema for Weight Loss; Shares Rise
|
|
Jun 10
|
Novo Nordisk Stock Climbs on Report of Activist Investor Parvus Building Stake
|
|
Jun 10
|
Plug Power's Uzbekistan plant, Novo Nordisk activist investor
|
|
Jun 10
|
Weight-Loss Drugs Pose Long-Term Threat To McDonald's: Analyst
|
|
Jun 10
|
Novo Nordisk Stock Climbs on Report Parvus Asset Taking Stake
|
|
Jun 10
|
ADA 2025: Novo Nordisk highlights strong portfolio data with new semaglutide and CagriSema results, redefining possibilities in obesity and diabetes care
|
|
Jun 10
|
Analysis: Hims & Hers says its weight-loss business can grow as US market changes
|
|
Jun 10
|
2 Weight Loss Drug Stocks That Are Screaming Buys in June
|